Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Quadrivalent split-virion influenza vaccine in healthy subjects ≥3 years
CTR20150835Phase 3Completed
- Sponsor
- Jiangsu gdk Biotechnology Co., Ltd.
- Start
- Feb 2016
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of quadrivalent inactivated split virion influenza vaccine in influenza, sponsored by Jiangsu gdk Biotechnology Co., Ltd.. Started Feb 2016; status: completed.
02
Drugs
quadrivalent inactivated split virion influenza vaccine
03
Conditions
influenza
Beyond the preview
Go deeper on CTR20150835.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20150835.